BEGIN:VCALENDAR VERSION:2.0 PRODID:-//hacksw/handcal//NONSGML v1.0//EN BEGIN:VEVENT UID:41dff37d5f2500556d111177ade0e43b DTSTAMP:20260604T153957Z DTSTART:20251119T130000 DTEND:20251119T143000 SUMMARY:WHO PCV vaccination recommendations: 1p+1 dose schedules DESCRIPTION:Dear colleagues,\nWe are delighted to invite you to a new webinar: WHO PCV vaccination recommendations: 1p+1 dose schedules organised by the WHO and TechNet.\nThe World Health Organization (WHO) has released an updated Position Paper on Pneumococcal Conjugate Vaccine (PCV) vaccination, introducing new recommendations on dose-reduced schedules, including the 2-dose “1p+1” schedule (one primary dose plus one booster dose). While the 1p+1 schedule is not yet included in current PCV product licenses, WHO notes that off-label use may be justified under specific national conditions and with expert recommendations — offering potential benefits in cost savings and reduction of injections.\nThis webinar will:\n\nPresent the updated WHO recommendations on PCV vaccination.\nDiscuss key considerations for countries exploring the adoption of the 1p+1 schedule.\nProvide insights relevant to national immunization programme decisions.\n\nTarget audience:\n\nWHO and UNICEF colleagues (regional and country levels)\nNational immunization programme managers\nImmunization partners and technical agencies\n\nThe webinar will be conducted in English, with simultaneous interpretation in French.\nWhen: Wednesday, November 19th, 1pm-2.30pm CET\nRegistration: https://who.zoom.us/webinar/register/WN_0NQIwZmfRhK1OnPfMNQdtg#/registration  X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\n

Dear colleagues,


We are delighted to invite you to a new webinar: WHO PCV vaccination recommendations: 1p+1 dose schedules organised by the WHO and TechNet.


The World Health Organization (WHO) has released an updated Position Paper on Pneumococcal Conjugate Vaccine (PCV) vaccination, introducing new recommendations on dose-reduced schedules, including the 2-dose “1p+1” schedule (one primary dose plus one booster dose). While the 1p+1 schedule is not yet included in current PCV product licenses, WHO notes that off-label use may be justified under specific national conditions and with expert recommendations — offering potential benefits in cost savings and reduction of injections.


This webinar will:



Target audience:



The webinar will be conducted in English, with simultaneous interpretation in French.


When: Wednesday, November 19th, 1pm-2.30pm CET


Registration: https://who.zoom.us/webinar/register/WN_0NQIwZmfRhK1OnPfMNQdtg#/registration 

\n\n\n LOCATION: END:VEVENT END:VCALENDAR